| scholarly article | Q13442814 |
| P50 | author | Tufaria Mussa | Q57476180 |
| Esther Blanco | Q39763972 | ||
| Juan Barcena | Q42819541 | ||
| Lorenzo Fraile | Q43237293 | ||
| María Montoya | Q43237300 | ||
| Elisa Crisci | Q45346582 | ||
| Llilianne Ganges | Q45382457 | ||
| Jorge Martínez | Q53111598 | ||
| P2093 | author name string | C Costa | |
| N Moreno | |||
| M Baratelli | |||
| P Martinez-Orellana | |||
| R Cabezón | |||
| P2860 | cites work | Comparative genomics of foot-and-mouth disease virus | Q24522726 |
| Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig | Q28743371 | ||
| International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants | Q33464056 | ||
| Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. | Q33805171 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| Optimal combinations of acute phase proteins for detecting infectious disease in pigs. | Q34774310 | ||
| Virus-like particles as vaccines and vessels for the delivery of small molecules | Q35961197 | ||
| Virus-like particles: passport to immune recognition | Q36602264 | ||
| Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection | Q36636635 | ||
| Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. | Q36659320 | ||
| Recombinant vaccine for canine parvovirus in dogs | Q36697229 | ||
| Recombinant virus vaccine for bluetongue disease in sheep | Q36805280 | ||
| Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II. | Q36994520 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Serum acute phase proteins as biomarkers of pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs | Q57207384 | ||
| Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses | Q57207435 | ||
| Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations | Q60023689 | ||
| Papillomavirus-like particles induce acute activation of dendritic cells | Q73785306 | ||
| Virus-like particles as a vaccine delivery system: myths and facts. | Q37148127 | ||
| The coming of age of virus-like particle vaccines | Q37309265 | ||
| Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design | Q37792984 | ||
| Current strategies for subunit and genetic viral veterinary vaccine development. | Q37840709 | ||
| Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs | Q39558062 | ||
| Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery | Q39588697 | ||
| Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. | Q39602247 | ||
| Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. | Q39763867 | ||
| Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs | Q39891157 | ||
| Human NK cell-mediated cytotoxicity triggered by CD86 and Gal alpha 1,3-Gal is inhibited in genetically modified porcine cells | Q40739780 | ||
| The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. | Q41628578 | ||
| Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV. | Q42033745 | ||
| Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. | Q42047559 | ||
| Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus | Q42067386 | ||
| A method for producing recombinant baculovirus expression vectors at high frequency. | Q42070060 | ||
| Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant | Q43582320 | ||
| Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs | Q44317220 | ||
| A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. | Q44400704 | ||
| Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose | Q44413898 | ||
| Interaction of porcine conventional dendritic cells with swine influenza virus. | Q45362870 | ||
| Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice | Q45366866 | ||
| Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. | Q45369927 | ||
| Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response | Q45392035 | ||
| Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells. | Q45413459 | ||
| The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells | Q45730227 | ||
| Simultaneous expression of recombinant baculovirus-encoded chicken anaemia virus (CAV) proteins VP1 and VP2 is required for formation of the CAV-specific neutralizing epitope | Q45751924 | ||
| Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. | Q45877185 | ||
| Protective efficacy of virus-like particles for bluetongue disease | Q45880426 | ||
| Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway | Q46049450 | ||
| Phenotypical and functional characterization of clinical grade dendritic cells. | Q52010684 | ||
| Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties | Q56775510 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2427-2439 | |
| P577 | publication date | 2012-02-03 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Chimeric calicivirus-like particles elicit specific immune responses in pigs | |
| P478 | volume | 30 |
| Q28080092 | Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs |
| Q42203587 | Chimeric influenza-virus-like particles containing the porcine reproductive and respiratory syndrome virus GP5 protein and the influenza virus HA and M1 proteins |
| Q40983509 | Comparative analysis of rabbit hemorrhagic disease virus (RHDV) and new RHDV2 virus antigenicity, using specific virus-like particles |
| Q34608302 | Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine |
| Q92702312 | Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective |
| Q42255299 | Immune characterization of long pentraxin 3 in pigs infected with influenza virus |
| Q55266915 | Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus. |
| Q42241580 | Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA). |
| Q42217677 | Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice |
| Q35803488 | Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System |
| Q37195802 | Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses. |
| Q42284484 | Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle. |
| Q35076683 | Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q62128249 | Virus-like particle-based vaccines for animal viral infections |
| Q38088523 | Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development |
| Q38019283 | Virus-like particles: the new frontier of vaccines for animal viral infections. |
Search more.